4D PHARMA PLC's ticker is LBPSW and the CUSIP is 35085K117. A total of 5 filers reported holding 4D PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -88.2% | 42,326 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $17,000 | -32.0% | 42,326 | -10.6% | 0.00% | -33.3% |
| Q4 2021 | $25,000 | -24.2% | 47,326 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $33,000 | -32.7% | 47,326 | -5.3% | 0.01% | -37.5% |
| Q2 2021 | $49,000 | -10.9% | 50,000 | 0.0% | 0.01% | -27.3% |
| Q1 2021 | $55,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Walleye Capital LLC | 16,000 | $1,000 | 0.00% |
| Yakira Capital Management, Inc. | 42,326 | $2,000 | 0.00% |
| AQR Arbitrage LLC | 55,653 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HRT FINANCIAL LP | 40,178 | $1,000 | 0.00% |